Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022
September 07 2022 - 11:00AM
Business Wire
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the
“Company”), a leader in PCR-based DNA technologies, today announced
it will be featured as a presenting company at the H.C. Wainwright
24th Annual Global Investment Conference on September 13, 2022, at
2:00 pm Eastern Time. The conference is being held as a hybrid
in-person/virtual event from September 12 to 14, 2022.
Applied DNA’s CEO and Chairman of the Board of Directors, Dr.
James A. Hayward, will present in person and provide an overview of
the Company’s business during the presentation.
To listen to a livestream of the Company’s presentation, please
click on the following link to register for the conference: Applied
DNA presentation at the H.C. Wainwright 24th Annual Global
Investment Conference
Event: H.C. Wainwright 24th Annual Global Investment
Conference (Hybrid Conference)
Date: September 13, 2022
Time: 2:00 pm Eastern Time
Location: In-person at the Lotte New York Palace Hotel,
New York, NY.
Note: To schedule a one-on-one with management, please
get in touch with your H.C. Wainwright representative.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing
technologies to produce and detect deoxyribonucleic acid (“DNA”).
Using PCR to enable both the production and detection of DNA, we
operate in three primary business markets: (i) the manufacture of
DNA for use in nucleic acid-based therapeutics; (ii) the detection
of DNA in molecular diagnostics testing services; and (iii) the
manufacture and detection of DNA for industrial supply chain
security services.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company’s common stock is listed on NASDAQ under the ticker
symbol ‘APDN,’ and its publicly traded warrants are listed on OTC
under the ticker symbol ‘APPDW.’
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220907005997/en/
Investor Relations Contact: Sanjay M. Hurry,
917-733-5573, sanjay.hurry@adnas.com Web: www.adnas.com
Twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024